NCT02499081 2021-06-11UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib TreatmentUniversity of ArkansasPhase 2 Completed20 enrolled 9 charts
NCT00932698 2019-08-07Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple MyelomaTakedaPhase 1 Completed60 enrolled 34 charts